Outcome Of Chronic Kidney Disease Patients On The Basis Of Referral To Nephrologist: A One-year Follow-up Study

Anees, Muhammad; Hussain, Yasir; Ibrahim, Muhammad; Ilahi, Irfan; Ahmad, Sajjad; Asif, Khushbakht Isma; Jameel, Amina

doi:10.29271/jcpsp.2018.04.304

Cited by 11 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results indicate that the vast majority of our patients have anaemia. Similar results were reported by Anees et al, 2018 who found that 91.2% of kidney failure patients had anaemia [9]. Indeed, the endogenous erythropoietin deficiency, the uremic inhibitors and the shortened red blood cells survival are the main cause of anaemia in haemodialysis patients [10].…”

Section: Resultssupporting

confidence: 84%

Gender Effect on Some Blood Parameters in Patients Undergoing Haemodialysis in North Western Algeria

et al. 2020

View full text Add to dashboard Cite

Replacement therapy for chronic kidney disease using haemodialysis involves the elimination of excessive toxic fluids and toxic metabolic end products from the body. Worldwide, gender significant differences exist with regard to the epidemiological aspect, evolution and blood parameters of chronic renal failure disease. In the present retrospective study, 289 medical files of adult patients (154 men and 135 women) aged 20 to 78 years were investigated to understand the relationship between gender difference and blood parameters in patients with chronic renal failure undergoing haemodialysis in north western Algeria. Our results revealed significant higher levels of haemoglobin (p=0.003), haematocrit (p=0.005), creatinine (p<0.001) and uric acid (p=0.037) in men comparing to women. However, women serum samples were characterized by higher significant level of platelets (p=0.002). No significant differences (p˃0.005) were observed between the two genders regarding the other parameters of blood count formula, liver function parameters, urea, mineral status (calcemia and phosphoremia), basic biochemical levels (glycaemia and lipids), C-reactive protein (CRP) and parathyroid hormone (PTH). In dialysis patients, and despite the fact that some serum parameters vary significantly, the majority of the parameters recorded were often high in the males compared to the female gender. This finding may be due to the existence of specific confounding prognostic factors for each sex, which may or may not compensate for each other, therefore, ultimately, leading to overall non-significance.

show abstract

Section: Resultssupporting

confidence: 84%

Gender Effect on Some Blood Parameters in Patients Undergoing Haemodialysis in North Western Algeria

et al. 2020

View full text Add to dashboard Cite

show abstract

“…In this study, major cause of ESRD was diabetes mellitus and hypertension which is similar to local and international studies but has changed since last decade locally when chronic GN was the leading cause of ESRD. 9,12,13 It may be due to better infection control measures that the prevalence of ESRD due to infectious GN has decreased and at the same time our dietary habits have changed leading to more metabolic syndrome and prevalence of Diabetes Mellitus. Anemia is an important predictor of morbidity and mortality for the dialysis patients.…”

Section: Resultsmentioning

confidence: 99%

Anemia and Mineral Bone Disorders in Patients with End Stage Renal Disease on Maintenance Hemodialysis

Anees¹,

Ahmad²,

Raja³

et al. 2021

Pak J Kidney Dis

Self Cite

View full text Add to dashboard Cite

Objective: To observe the pattern of anemia and mineral bone disorders (MBD)in patients with End Stage Renal Disease (ESRD) on maintenance hemodialysis (MHD) at Nephrology Department, Mayo Hospital and Shalamar Hospital, Lahore. Methodology: Two hundred patients who were undergoing MHD for more than three months were included in the study. Patients with Acute Kidney Injury (AKI) were excluded from the study. Patient’s demographic data, laboratory reports and dialysis record were noted in a predesigned proforma. Results: Two hundred patients were included in study, 105(52.5%) were male and rest of them were female. Major cause of ESRD was Diabetes Mellitus 83 (41.5%) followed by Hypertension 80 (40%) and Nephrolithiasis 15 (7.5%). Most of the patients belonged to middle age group, poor socioeconomic class, lower level of education and were getting twice-weekly dialysis. Mean hemoglobin was 10.17±1.69 gm/L and most of the patients 137 (68.5%) were anemic with hemoglobin level less than 11gm/dl. Iron was adequate in 170 (85%) patients with transferrin saturation more than 20%. Hypocalcemia (<8.5mg/dl), hypophosphatemia and calcium phosphorus product was less than 55 in 138(69%), 42(21%), 175(87.5%) respectively. Intact PTH was less than 100 pg/ml in 16(8.0%) patients supporting adynamic bone disease according to KDOQI guidelines and rest of the patients 184(92%) were having Intact PTH more than 100 pg/ml. Conclusion: In this study, most of the patients were anemic most probably due to low dose of EPO and inadequate dialysis. High turnover and mixed bone disorders were present in majority of the patients.

show abstract

“…In our study, troponin value was high in AMI patients and no correlation was found between IMA and troponin. In (23,24).…”

Section: Discussionmentioning

confidence: 99%

Diagnostic Value of Ischemia-Modified Albumin in Terms of Acute Coronary Syndromes in Chronic Renal Patients Admitted to Emergency Department with Chest Pain and/or Equivalent Symptoms

Gökçek¹,

Sönmez²,

Yücel³

et al. 2022

esmj

View full text Add to dashboard Cite

Introduction:This study aimed to reveal the diagnostic value of Ischemia-Modified Albumin (IMA) in terms of acute coronary syndromes in chronic renal patients admitted to emergency department with chest pain and equivalent symptoms. Methods: Our study is a descriptive cross-sectional research and included 125 chronic renal patients admitted to emergency department with chest pain and/or equivalent symptoms and 96 healthy volunteers as the control group. Results: In our study, acute coronary syndrome (ACS) was detected in 12 (9.6%) of the patients. Mean IMA level was 0.72±0.17 absorbance units (ABSU) in the group with Chronic renal disease (CRD)+ACS, 0.71±0.16 ABSU in patients with CRD but without ACS, and 0.47±0.14 ABSU in the control group. A statistically significant difference was found between the groups. While no difference between chronic renal patients in whom ACS developed and chronic renal patients in whom ACS did not develop was recorded in terms of IMA. IMA value of both patients with CRD and chronic renal patients in whom ACS developed was significantly higher than that of the healthy control group. In our study, no correlation was found between troponin levels and IMA. Conclusion: IMA level increases in both CRD and ACS. Therefore, it was determined that IMA level did not significantly increase although ACS developed depending on already high IMA level in patients with CRD. We believe IMA cannot be safely used for the diagnosis of ACS in patients with CRD due to the low specificity rate and absence of an optimal threshold value.

show abstract

Outcome Of Chronic Kidney Disease Patients On The Basis Of Referral To Nephrologist: A One-year Follow-up Study

Abstract: There is no difference on the outcome of dialysis patients on the basis referral to nephrologist. Factors affecting overall mortality in both groups were financial status, metabolic acidosis, and temporary access for dialysis. Most of the patients were referred late to the nephrologists.

Cited by 11 publications

References 0 publications

Gender Effect on Some Blood Parameters in Patients Undergoing Haemodialysis in North Western Algeria

Gender Effect on Some Blood Parameters in Patients Undergoing Haemodialysis in North Western Algeria

Anemia and Mineral Bone Disorders in Patients with End Stage Renal Disease on Maintenance Hemodialysis

Diagnostic Value of Ischemia-Modified Albumin in Terms of Acute Coronary Syndromes in Chronic Renal Patients Admitted to Emergency Department with Chest Pain and/or Equivalent Symptoms

Contact Info

Product

Resources

About